Peanut Component Panel

Overview

  • EPIC Code:
  • IMO2932
  • Soft Test Code:
  • PEANP
  • Send Out Test Code:
  • 91681
Alternate Names
  • Allergen, Peanut Components
  • ImmunoCAP®
Included Tests

Ara h 2 (f423); Ara h 1 (f422); Ara h 3 (f424); Ara h 9 (f427); Ara h 8 (f352)


Clinical Significance

The ImmunoCAP® Peanut Component Allergen Test helps to assess a patient's level of risk of a life-threatening reaction, and may reassure patients when the risk for allergic symptoms is low or when they will most likely experience mild or localized reactions upon exposure to peanut. The test helps the health care provider identify primary, species-specific allergic sensitization, differentiate between symptoms caused by a primary allergen source and those caused by cross-reactivity, assess the level of risk for life-threatening allergic reactions, and provide clarity regarding the patient's risk of an allergic reaction to ease fears and help target effective management.


Specimen Collection & Preparation

Specimen Requirements

1.0 mL Serum in a SST Gold Top Tube


Alternate Specimen

1.0 mL Serum from a Red Top Tube in a Plastic Vial


TransportAndStorage

14 days Ambient (Transport)
14 days Refrigerated
30 days Frozen


Collection Instructions

 


Minimum Volume

0.6 mL Serum


Neonatal Volumne

Clinical Interpretation

Reference Range:

Ara h 1 (f422) <0.10 kU/L
Ara h 2 (f423) <0.10 kU/L
Ara h 3 (f424) <0.10 kU/L
Ara h 9 (f427) <0.10 kU/L
Ara h 6 (f447) <0.10 kU/l
Ara h 8 (f352) <0.10 kU/L


Methodology:
  • Immunoassay (IA)

Clinical Significance

The ImmunoCAP® Peanut Component Allergen Test helps to assess a patient's level of risk of a life-threatening reaction, and may reassure patients when the risk for allergic symptoms is low or when they will most likely experience mild or localized reactions upon exposure to peanut. The test helps the health care provider identify primary, species-specific allergic sensitization, differentiate between symptoms caused by a primary allergen source and those caused by cross-reactivity, assess the level of risk for life-threatening allergic reactions, and provide clarity regarding the patient's risk of an allergic reaction to ease fears and help target effective management.


Production Schedule

Sites Performed
  • Quest - Chantilly
Days Performed
Monday
Tuesday
Wednesday
Thursday
Friday
Departments
  • Sendouts - Clinical
Turn Around Time

4 to 5 days


Coding & Compliance

CDM

00918225, 00918759, 00918760, 00918761, 00918762 and 00918763


CPT Coding

86008 (x 6)


Medical Necessity May Apply